The above assessment of TIF from mice bearing IL-33+ vs. IL-33− 1492 glioma showed that chemokines, such as CCL2, CCL5, KC, and CXCL10 are enriched within the IL-33+ tumor microenvironment (Fig. 7a). This evidence concerns the gene CCL2 and central nervous system cancer.